Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 3
1(25.0%)
Phase 2
1(25.0%)
4Total
N/A(2)
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03258164Phase 3Completed

Cosmetic Fat Transplantation Using Expanded ASC Enriched Fat Grafts

Role: collaborator

NCT05079243Not ApplicableUnknown

Dermal and Subcutaneous Augmentation and Skin Assessment After Fat-, Stem Cell and Scaffold Injections

Role: collaborator

NCT02714907Not ApplicableCompleted

Clinical Data Validation of Novel Wireless Cortrium C3 Monitor for Continuous Electrocardiogram Measurements

Role: collaborator

NCT02788071Phase 2Completed

Effect of Fecal Microbiota Transplantation in Irritable Bowel Syndrome

Role: lead

All 4 trials loaded